Billing, H., Rieger, S., Süsal, C., Waldherr, R., Opelz, G., Wühl, E., & Tönshoff, B. (2012). IVIG and rituximab for treatment of chronic antibody-mediated rejection: A prospective study in paediatric renal transplantation with a 2-year follow-up. Transplant international, 25(11), . https://doi.org/10.1111/j.1432-2277.2012.01544.x
Chicago-Zitierstil (17. Ausg.)Billing, Heiko, Susanne Rieger, Caner Süsal, Rüdiger Waldherr, Gerhard Opelz, Elke Wühl, und Burkhard Tönshoff. "IVIG and Rituximab for Treatment of Chronic Antibody-mediated Rejection: A Prospective Study in Paediatric Renal Transplantation with a 2-year Follow-up." Transplant International 25, no. 11 (2012). https://doi.org/10.1111/j.1432-2277.2012.01544.x.
MLA-Zitierstil (9. Ausg.)Billing, Heiko, et al. "IVIG and Rituximab for Treatment of Chronic Antibody-mediated Rejection: A Prospective Study in Paediatric Renal Transplantation with a 2-year Follow-up." Transplant International, vol. 25, no. 11, 2012, https://doi.org/10.1111/j.1432-2277.2012.01544.x.